CoChat

Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK

Open access

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Abstract

ShK, from the sea anemone Stichodactyla helianthus, is a 35-residue disulfide-rich peptide that blocks the voltage-gated potassium channel Kv1.3 at ca. 10 pM and the related channel Kv1.1 at ca. 16 pM. We developed an analog of this peptide, ShK-186, which is currently in Phase 1b-2a clinical trials for the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. While ShK-186 displays a >100-fold improvement in selectivity for Kv1.3 over Kv1.1 compared with ShK, there is considerable interest in developing peptides with an even greater selectivity ratio. In this report, we describe several variants of ShK that incorporate p-phophono-phenylalanine at the N-terminus coupled with internal substitutions at Gln16 and Met21. In addition, we also explored the combinatorial effects of these internal substitutions with an alanine extension at the C-terminus. Their selectivity was determined by patch-clamp electrophysiology on Kv1.3 and Kv1.1 channels stably expressed in mouse fibroblasts. The peptides with an alanine extension blocked Kv1.3 at low pM concentrations and exhibited up to 2250-fold selectivity for Kv1.3 over Kv1.1. Analogs that incorporates p-phosphono-phenylalanine at the N-terminus blocked Kv1.3 with IC50s in the low pM range and did not affect Kv1.1 at concentrations up to 100 nM, displaying a selectivity enhancement of >10,000-fold for Kv1.3 over Kv1.1. Other potentially important Kv channels such as Kv1.4 and Kv1.6 were only partially blocked at 100 nM concentrations of each of the ShK analogs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/md13010529

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sequence alignment of K+ channel blocking peptides from sea anemones. The GenBank accession codes are also indicated. Alignment of the sequences is via the Cysteine residues which are shaded in gray with the pairings indicated by the lines linking them. The yellow highlighted areas are indicating sequence identity. The cyan colored residues indicate the key pore blocking residues. The green region with the (conserved Gly residue in pink) represents a sequence insertion present in the BgK-type anemone toxins.
Figure 1 Sequence alignment of K+ channel blocking peptides from sea anemones. The GenBank accession codes are also indicated. Alignment of the sequences is via the Cysteine residues which are shaded in gray with the pairings indicated by the lines linking them. The yellow highlighted areas are indicating sequence identity. The cyan colored residues indicate the key pore blocking residues. The green region with the (conserved Gly residue in pink) represents a sequence insertion present in the BgK-type anemone toxins.CC BY · PubMed Central
Figure 2 The solution structure of ShK in blue (PDB 1ROO) (A) compared with the scorpion toxin kaliotoxin in dark red (PDB 2UVS) (B). The side chains of critical residues are shown in stick format and colored navy blue (Arg), orange-red (Gln), magenta (Tyr), light-blue (Lys) and orange (Met).
Figure 2 The solution structure of ShK in blue (PDB 1ROO) (A) compared with the scorpion toxin kaliotoxin in dark red (PDB 2UVS) (B). The side chains of critical residues are shown in stick format and colored navy blue (Arg), orange-red (Gln), magenta (Tyr), light-blue (Lys) and orange (Met).CC BY · PubMed Central
Figure 3 Sequences of ShK analogs described in this study.
Figure 3 Sequences of ShK analogs described in this study.CC BY · PubMed Central
Figure 4 (A) RP-HPLC analysis of oxidative folding of ShK-223 after overnight folding (gradient conditions 10%–70% B in 30 min, 1 mL/min, A220 (absorbance at 220 nm), 0.1 AUFS (absorbance full scale) (B) RP-HPLC analysis of the purified ShK-223; (C) ESI-MS analysis of the multi-charged ions from ShK-223; (D) RP-HPLC analysis of oxidative folding of ShK-224 after overnight folding; (E) RP-HPLC analysis of the purified ShK-224; (F) ESI-MS analysis of the multi-charged ions from ShK-224. (Asterisk indicates correctly folded ShK peptides).
Figure 4 (A) RP-HPLC analysis of oxidative folding of ShK-223 after overnight folding (gradient conditions 10%–70% B in 30 min, 1 mL/min, A220 (absorbance at 220 nm), 0.1 AUFS (absorbance full scale) (B) RP-HPLC analysis of the purified ShK-223; (C) ESI-MS analysis of the multi-charged ions from ShK-223; (D) RP-HPLC analysis of oxidative folding of ShK-224 after overnight folding; (E) RP-HPLC analysis of the purified ShK-224; (F) ESI-MS analysis of the multi-charged ions from ShK-224. (Asterisk indicates correctly folded ShK peptides).CC BY · PubMed Central
Figure 5 (A) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-223; (B) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-224; (C) Dose-response effects of ShK (▲), ShK-223 (●), and ShK-224 (○) on Kv1.3 (left) and Kv1.1 (right) currents (n = 3 to 6 cells per concentration).
Figure 5 (A) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-223; (B) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-224; (C) Dose-response effects of ShK (▲), ShK-223 (●), and ShK-224 (○) on Kv1.3 (left) and Kv1.1 (right) currents (n = 3 to 6 cells per concentration).CC BY · PubMed Central
Figure 6 (A) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-234; (B) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-235; (C) Dose-response effects of ShK-234 (▲) and ShK-235 (●) on Kv1.3 (left) and Kv1.1 (right) currents (n = 3 to 4 cells per concentration).
Figure 6 (A) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-234; (B) Whole-cell Kv1.3 (left) and Kv1.1 (right) currents before (control) and after addition of ShK-235; (C) Dose-response effects of ShK-234 (▲) and ShK-235 (●) on Kv1.3 (left) and Kv1.1 (right) currents (n = 3 to 4 cells per concentration).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Pennington M.W. Kem W.R. Karlsson E. Sea anemone potassium channel toxins Guidebook to Protein Toxins and Their Use in Cell Biology Montecucco C.A.R. Oxford University Press Oxford, UK 1997 159 161

Cited by

Metadata

Authors
Pennington, M., Chang, S., Chauhan, S., Huq, R., Tajhya, R., Chhabra, S., Norton, R., & Beeton, C.
Affiliations
  • Peptides International (United States) (US)
  • Monash University (AU)
  • Baylor College of Medicine (US)
Corresponding author
Pennington, Michael
Venue
Marine Drugs
Publisher
MDPI AG
Published
2015-01-16
Volume
13
Issue
1
Pages
529-542
ISSN
1660-3397 (ISSN-L)
OpenAlex
W2008077937
Cited by
70
References
38
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 5 · 2017: 9 · 2016: 4 · 2015: 3
FWCI
3.33
Type
journal article
Language
en
Open access
Locations
  • Marine Drugs (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Monash University Research Portal (Monash University) (submittedVersion, other-oa)
Funders
NIH (NS073712)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
Kv1.3 potassium channel, Kv1.1, voltage-gated potassium channels, disulfide-rich peptides, peptide analogues, channel selectivity, Kv1.4, Kv1.6, autoimmune disease therapy, Stichodactyla helianthus
MeSH terms
Amino Acid Sequence, Animals, Chromatography, High Pressure Liquid, Dose-Response Relationship, Drug, Molecular Sequence Data, Peptides, Sea Anemones, Patch-Clamp Techniques, Inhibitory Concentration 50, Kv1.1 Potassium Channel, Kv1.3 Potassium Channel, Chromatography, Reverse-Phase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.